U.S. Clinical Trials Supply And Logistics Market Size, Share & Trends Analysis Report By Service, By Phase (Phase I, Phase II), By Therapeutic Area (Oncology, Cardiovascular), By End-user, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Service
                        1.2.2. Phase
                        1.2.3. Therapeutic Area
                        1.2.4. End-user
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Italy
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Services
                        2.2.2. Phase
                        2.2.3. Therapeutic Area
                        2.2.4. End-user
                    2.3. Competitive Insights
Chapter 3. U.S. Clinical Trials Supply and Logistics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                    3.3. Market Driver Analysis
                        3.3.1. Increasing R&D investments by pharmaceutical and biopharmaceutical firms
                        3.3.2. Technological Advancements in Supply Chain
                        3.3.3. Expansion of Clinical Trial Sites
                    3.4. Market Restraint Analysis
                        3.4.1. Stringent Regulations Pertaining to Logistics
                        3.4.2. Counterfeiting Of Drugs
                    3.5. Industry Analysis - Porter’s Five Forces
                        3.5.1. Supplier power
                        3.5.2. Buyer power
                        3.5.3. Substitution threat
                        3.5.4. Threat of new entrant
                        3.5.5. Competitive rivalry
                    3.6. PESTEL Analysis
                        3.6.1. Political landscape
                        3.6.2. Technological landscape
                        3.6.3. Economic Landscape
Chapter 4. U.S. Clinical Trials Supply and Logistics Market Services Estimates & Trend Analysis
                    4.1. U.S. Clinical Trials Supply and Logistics Service Model Dashboard
                    4.2. U.S. Clinical Trials Supply and Logistics Market Service Movement Analysis
                    4.3. Logistics & Distribution
                        4.3.1. Logistics & Distribution Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Storage and Retention
                        4.4.1. Storage and Retention Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Packaging, Labeling, and Blinding
                        4.5.1. Packaging, Labeling, and Blinding Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Manufacturing
                        4.6.1. Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.7. Comparator sourcing
                        4.7.1. Comparator Sourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.8. Other services (solutions, ancillary supply)
                        4.8.1. Other services (solutions, ancillary supply) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Clinical Trials Supply and Logistics Market Phase Estimates & Trend Analysis
                    5.1. U.S. Clinical Trials Supply and Logistics Phase Model Dashboard
                    5.2. U.S. Clinical Trials Supply and Logistics Market Phase Movement Analysis
                    5.3. Phase I
                        5.3.1. Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Phase II
                        5.4.1. Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Phase III
                        5.5.1. Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Phase IV
                        5.6.1. Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Clinical Trials Supply and Logistics Market Therapeutic Area Estimates & Trend Analysis
                    6.1. U.S. Clinical Trials Supply and Logistics Therapeutic Area Model Dashboard
                    6.2. U.S. Clinical Trials Supply and Logistics Market Therapeutic Area Movement Analysis
                    6.3. Testing Category Dashboard
                    6.4. Oncology
                        6.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. CNS &Mental Disorders
                        6.5.1. CNS &Mental Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Cardiovascular
                        6.6.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Respiratory Disease
                        6.7.1. Respiratory Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.8. Others
                        6.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Clinical Trials Supply and Logistics Market End-user Estimates & Trend Analysis
                    7.1. U.S. Clinical Trials Supply and Logistics Market End-user Model Dashboard
                    7.2. U.S. Clinical Trials Supply and Logistics Market End-user Movement Analysis
                    7.3. Pharmaceutical
                        7.3.1. Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Biologics
                        7.4.1. Biologics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. Medical Device
                        7.5.1. Medical Device Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                        8.2.1. Vendor Landscape
                        8.2.2. List of key distributors and channel partners
                        8.2.3. Key customers
                        8.2.4. Key company market share analysis, 2023
                    8.3. Catalent, Inc
                        8.3.1. Company Overview
                        8.3.2. Financial performance
                        8.3.3. Product benchmarking
                        8.3.4. Strategic initiatives
                    8.4. PCI Pharma Service
                        8.4.1. Company overview
                        8.4.2. Financial performance
                        8.4.3. Product benchmarking
                        8.4.4. Strategic initiatives
                    8.5. Thermo Fisher Scientific, Inc
                        8.5.1. Company overview
                        8.5.2. Financial performance
                        8.5.3. Product benchmarking
                        8.5.4. Strategic initiatives
                    8.6. Marken
                        8.6.1. Company overview
                        8.6.2. Financial performance
                        8.6.3. Product benchmarking
                        8.6.4. Strategic initiatives
                    8.7. Parexel International Corporation
                        8.7.1. Company overview
                        8.7.2. Financial performance
                        8.7.3. Product benchmarking
                        8.7.4. Strategic initiatives
                    8.8. Piramal Pharma Solutions
                        8.8.1. Company overview
                        8.8.2. Financial performance
                        8.8.3. Product benchmarking
                        8.8.4. Strategic initiatives
                    8.9. UDG Healthcare
                        8.9.1. Company overview
                        8.9.2. Financial performance
                        8.9.3. Product benchmarking
                        8.9.4. Strategic initiatives
                    8.10. DHL
                        8.10.1. Company Overview
                        8.10.2. Financial performance
                        8.10.3. Product benchmarking
                        8.10.4. Strategic initiatives
                    8.11. FedEx
                        8.11.1. Company Overview
                        8.11.2. Financial performance
                        8.11.3. Product benchmarking
                        8.11.4. Strategic initiatives
                    8.12. Packaging Coordinators, Inc.
                        8.12.1. Company Overview
                        8.12.2. Financial performance
                        8.12.3. Product benchmarking
                        8.12.4. Strategic initiatives
                    8.13. PRA Heath sciences
                        8.13.1. Company Overview
                        8.13.2. Financial performance
                        8.13.3. Product benchmarking
                        8.13.4. Strategic initiatives
                    8.14. Myonex, Inc
                        8.14.1. Company Overview
                        8.14.2. Financial performance
                        8.14.3. Product benchmarking
                        8.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Clinical Trials Supply and Logistics, By Product, 2018 - 2030 (USD Billion)
Table 3 U.S. Clinical Trials Supply and Logistics, By Animal Type, 2018 - 2030 (USD Billion)
Table 4 U.S. Clinical Trials Supply and Logistics, By Sample Type, 2018 - 2030 (USD Billion)
Table 5 U.S. Clinical Trials Supply and Logistics, By Testing Category, 2018 - 2030 (USD Billion)
Table 6 U.S. Clinical Trials Supply and Logistics, By End-use, 2018 - 2030 (USD Billion)
Table 7 U.S. Clinical Trials Supply and Logistics, By Indication, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews In North America
Fig. 5 Primary Interviews In Europe
Fig. 6 Primary Interviews In APAC
Fig. 7 Primary Interviews In Latin America
Fig. 8 Primary Interviews In MEA
Fig. 9 Market Research Approaches
Fig. 10 Value-Chain-Based Sizing & Forecasting
Fig. 11 QFD Modeling For Market Share Assessment
Fig. 12 Market Formulation & Validation
Fig. 13 U.S. Clinical Trial Supply & Logistics Market: Market Outlook
Fig. 14 Clinical Trial Supply & Logistics Competitive Insights
Fig. 15 Parent Market Outlook
Fig. 16 Related/Ancillary Market Outlook
Fig. 17 Penetration And Growth Prospect Mapping
Fig. 18 Industry Value Chain Analysis
Fig. 19 U.S. Clinical Trial Supply & Logistics Market Driver Impact
Fig. 20 U.S. Clinical Trial Supply & Logistics Market Restraint Impact
Fig. 21 U.S. Clinical Trial Supply & Logistics Market Strategic Initiatives Analysis
Fig. 22 U.S. Clinical Trial Supply & Logistics Market: Service Movement Analysis
Fig. 23 U.S. Clinical Trial Supply & Logistics Market: Service Outlook And Key Takeaways
Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
Fig. 25 Storage & retention Market Estimates And Forecast, 2018 - 2030
Fig. 26 Packaging, labeling, and blinding Market Estimates And Forecast, 2018 - 2030
Fig. 27 Manufacturing Market Estimates And Forecast, 2018 - 2030
Fig. 28 Comparator Sourcing Market Estimates And Forecast, 2018 - 2030
Fig. 29 Other Market Estimates And Forecast, 2018 - 2030
Fig. 30 U.S. Clinical Trial Supply & Logistics Market: Phase Movement Analysis
Fig. 31 U.S. Clinical Trial Supply & Logistics Market: Phase Outlook And Key Takeaways
Fig. 32 Phase I Market Estimates And Forecasts, 2018 - 2030
Fig. 33 Phase II Market Estimates And Forecasts, 2018 - 2030
Fig. 34 Phase III Market Estimates And Forecasts, 2018 - 2030
Fig. 35 Phase IV Market Estimates And Forecasts, 2018 - 2030
Fig. 36 U.S. Clinical Trial Supply & Logistics Market: Therapeutic Area Movement Analysis
Fig. 37 U.S. Clinical Trial Supply & Logistics Market: Therapeutic Area Outlook And Key Takeaways
Fig. 38 Oncology Market Estimates And Forecasts, 2018 - 2030
Fig. 39 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
Fig. 40 Respiratory Disease Market Estimates And Forecasts, 2018 - 2030
Fig. 41 CNS & Mental Disorders Market Estimates And Forecasts, 2018 - 2030
Fig. 42 Others Market Estimates And Forecasts, 2018 - 2030
Fig. 43 U.S. Clinical Trial Supply & Logistics Market: End-Use Movement Analysis
Fig. 44 U.S. Clinical Trial Supply & Logistics Market: End Use Outlook And Key Takeaways
Fig. 45 Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030
Fig. 46 Biologicals Market Estimates And Forecasts, 2018 - 2030
Fig. 47 Medical Device Market Estimates And Forecasts, 2018 - 2030